Oruka Therapeutics (ORKA) SVP Finance Arjun Agarwal Sells 533 Shares

What Happened
Arjun Agarwal, Senior Vice President, Finance at Oruka Therapeutics (ORKA), disposed of 533 shares on September 21, 2026. The shares were sold at $95.75 each, for total proceeds of $51,035. This was a sale (not a purchase) and is typically considered a routine disposition rather than a bullish vote.

Key Details

• Transaction date and price: 2026-09-21 — 533 shares at $95.75 per share (total $51,035).
• Transaction type: Reported as an open-market or private sale (code S).
• Shares owned after transaction: Not specified in the supplied filing.
• Footnote: Sale was effected under a Rule 10b5-1 trading plan established on February 11, 2026 (pre-scheduled plan).
• Filing timeliness: Reported on 2026-09-21 (same day as the transaction period reported), indicating a timely Form 4 filing.

Context
Sales made under a 10b5-1 plan are pre-arranged and often reflect scheduled portfolio management or diversification rather than a change in the insider’s view of the company. For retail investors, purchases generally carry more weight as potential signals; routine, pre-planned sales like this one are common and not necessarily indicative of material insider sentiment.